Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomaterials|January 10, 2019
Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivoYan Li, Kum-Hee Yun, Hyeri Lee, et al.
Journal of Nanoscience and Nanotechnology|January 5, 2016
Gradient-Field-Plasma Modification of Imprinted NanopatternsSoohyun Kim, Dae Keun Park, Kum-Hee Yun, et al.
Cancer Research and Treatment|September 27, 2022
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment ResponseJung Yong Hong, Hee Jin Cho, Kum-Hee Yun, et al.
Cancers|December 11, 2022
Therapeutic Implications of TGF-β Pathway in Desmoid Tumor Based on Comprehensive Molecular Profiling and Clinicopathological PropertiesKum-Hee Yun, Changhee Park, Hyang Joo Ryu, et al.
Oncology|September 6, 2020
Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CAHyae Min Jeon, Jae Seok Lee, Soo Hee Kim, et al.
Cancer Research and Treatment|January 18, 2022
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial StudyJoonha Kwon, Jun Hyeong Lee, Young Han Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II StudyJin-Hee Ahn, Jeeyun Lee, Changhee Park, et al.
Nature Communications|January 23, 2024
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trialHee Jin Cho, Kum-Hee Yun, Su-Jin Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue SarcomaKum-Hee Yun, Nam Suk Sim, Su-Jin Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaChang Gon Kim, Nam Suk Sim, Jeong Eun Kim, et al.
Pageof 1